BIOLASE Announces Pricing of $7M Public Offering

Facebook X LinkedIn Email
LAKE FOREST, Calif., Feb. 13, 2024 — Dental laser developer and manufacturer BIOLASE, Inc. announced the price of its public offering of 16,000,000 units. Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $7 million.

The offering is expected to close on Feb. 15, subject to customary closing conditions. It follows BIOLASE's close of its $4.5 million underwritten public offering (Series J convertible redeemable preferred stock and warrants) last summer.

Per the latest offering, each unit is to consist of one share of common stock (or one pre-funded warrant to purchase one share of common stock); one Class A Warrant to purchase one share of common stock; and one Class B Warrant to purchase one share of common stock. Each unit is being sold at an effective public offering price of $0.44. The Class A Warrants will be immediately exercisable at a price of $0.66 per share.

Published: February 2024
BusinessIPOpublicLasersBiolaseBiophotonicsmedicaldentaldental laserAmericasstockinitial public offeringfundingpricingpublic offering

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.